XTX Topco’s Antares Pharma, Inc. ATRS Stock Holding History

XTX Topco’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,751	Closed	-$106K	–	1194
2022 Q1	$106K	Buy	+25,751	New	+$93.4K	0.05%	506
2021 Q3	–	Sell	-20,657	Closed	-$90K	–	1198
2021 Q2	$90K	Buy	+20,657	New	+$84.2K	0.03%	672

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

XTX Topco's ATRS Position: Q2 2022 in Review

XTX Topco sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 25,751 shares — an estimated $106K sold.

XTX Topco first reported a position in ATRS in Q2 2021 and held it in 2 quarters. The position peaked at $106K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

XTX Topco reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
XTX Topco sold 25,751 Antares Pharma, Inc. shares in Q2 2022, an estimated $106K.
XTX Topco first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 2 quarters.
XTX Topco's Antares Pharma, Inc. position peaked at $106K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on XTX Topco's 13F filing for Q2 2022, filed 15 Aug 2022.